The Investment Column: Premium pork producer Cranswick back on form and worth biting into


Our view: Buy

Share price: 564.5p (+31p)

The TV chef Jamie Oliver reckons that Sainsbury's customers should buy the supermarket's fresh fruit, vegetables and all the other things that are good for you. Holders of shares in pork producer Cranswick, which supplies Sainsbury's with its "taste the difference" range, would urge customers to buy sausages.

After Cranswick issued an update yesterday, watchers reckon things are getting better for the group after it published what some analysts took to be a worrying trading statement earlier in the year. The firm was worried about its ability to pass on the increasing cost of commodities to its customers, but according to watchers at Panmure Gordon, things are now in better order. "Having disappointed the market with its Q3 trading update in January, today's announcement of the Q4 performance sees the company reporting continued strong sales," they say.

The company's chairman Martin Davey says that there is always a time lag associated with passing these costs on and the company has now managed to do that in its primary processed pork business.

Analysts at Shore Capital reckon that the problems were associated with a lack of "visibility", but that has now also been resolved. "Management has confirmed that the full-year performance will be in-line with market expectations, and hence we leave our 2008 and 2009 forecasts unchanged," they say.

Despite what turned out to be a temporary issue on costs being resolved, the company does face other problems. The firm is generally thought to be at the upper end of the pork market, which Mr Davey reckons will insulate it from the worst effects of any credit crisis-related downturn. He may well be right, but there is an alternative argument that suggests customers faced with the need to do a bit of financial belt-tightening may opt for ordinary sausages rather than the premium range.

The group also imports meats from Italy for its charcuterie range. As it buys in euros and sells in sterling, the exchange rate is like to make a £600,000 dent in profitability this year.

Cranswick is over its early year wobble when its share priced dropped from 769p on 31 January to 560p just five days later. Better sentiment will see the stock rise. Buy.

Akers Biosciences

Our view: Buy

Share price: 13.75p (+0.25p)

The last 12 months have been something of a revelation for Akers Biosciences. The AIM-listed group develops and makes diagnostics products, including alcohol breath-testing devices, which it sells to the US military.

By the group's own admission, until last year the scientists were in charge. "The firm was great at creating science," says Tom Nicolette, Akers' chief executive. "We had government FDA approvals in place and have had $60m of investment since 2002. It was a real commercial opportunity."

The firm's annual results published yesterday show that the group is making progress. Revenues were up to $5.5m, versus just over $1m in 2006, with loses cut to $2.4m from more than $10m the year before.

Much of the change has been down to the take up of two products that have now received their US patents. Each department of the US military now buys the firm's breathscan system, which shows soldiers if they are sufficiently sober to use weapons. Health workers are buying up the firm's system for detecting blood clotting among potential users of the drug Herperin, which is supposed to thin the blood, but in some cases has done precisely the opposite, leading to the deaths of patients.

Analysts at Arbuthnot recommend a "strong buy", suggesting that Akers' strategy of targeting "carefully chosen key markets where existing tests do not effectively fulfil clinical... requirements," is on fire. Investors should note that Arbuthnot is the group's house broker.

The company reckons its strategy of protecting its technology through patent is crucial and that it has already taken action to prevent competitors copying it.

Independent analysts reckon the fact that the US military has contracted with the group "is not bad at all", and that investors should be interested. The firm's share price has fallen steadily from 71.5p last May, and that's a worry, but also potentially gives investors the hope of a good run. Buy.

Charles Taylor Consulting

Our view: Buy

Share price: 268p (+4p)

In a world worried about the credit crisis, investors know they should be seeking steady, defensive stocks to stave off the worst of the crunch.

And they don't come much steadier than Charles Taylor Consulting, which has been providing services to the insurance industry, in one form or another, since the 19th century. In short, the group, which posted a record £13.6m profit yesterday, is involved in a number of industries, from offering consultancy and investment services to mutuals to taking on troubled insurance firms and realising their value.

The firm faces several risks that analysts point out. The weak dollar is a big problem given the amount of business the firm does in the United States. Watchers at Dresdner Kleinwort recommend investors "cut" the stock, saying that foreign exchange rates are bad enough for the bank to cut its target share price from 500p to 425p. Dresdner does point to the progress being made by the firm, which increased revenues by 3 per cent last year to £81.5m.

The group targets stable improvements and chief executive John Rowe points to the long-standing relationships it has with its clients as a reason to back the stock. Buy.

Start your day with The Independent, sign up for daily news emails
ebooksA special investigation by Andy McSmith
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45,000: SThree: SThree Group have been well e...

Ashdown Group: IT Manager / Development Manager - NW London - £58k + 15% bonus

£50000 - £667000 per annum + excellent benefits : Ashdown Group: IT Manager / ...

Recruitment Genius: Sales Consultant / Telemarketer - OTE £20,000

£13000 - £20000 per annum: Recruitment Genius: Scotland's leading life insuran...

Ashdown Group: Training Programme Manager - City, London

£40000 - £45000 per annum + benefits : Ashdown Group: Training Programme Manag...

Day In a Page

Timeless drama of Championship race in league of its own - Michael Calvin

Michael Calvin's Last Word

Timeless drama of Championship race in league of its own
Where the spooks get their coffee fix: The busiest Starbucks in the US is also the most secretive

The secret CIA Starbucks

The coffee shop is deep inside the agency's forested Virginia compound
Revealed: How the Establishment closed ranks over fallout from Loch Ness Monster 'sighting'

How the Establishment closed ranks over fallout from Nessie 'sighting'

The Natural History Museum's chief scientist was dismissed for declaring he had found the monster
One million Britons using food banks, according to Trussell Trust

One million Britons using food banks

Huge surge in number of families dependent on emergency food aid
Excavation at Italian cafe to fix rising damp unearths 2,500 years of history in 3,000 amazing objects

2,500 years of history in 3,000 amazing objects

Excavation at Italian cafe to fix rising damp unearths trove
The Hubble Space Telescope's amazing journey, 25 years on

The Hubble Space Telescope's amazing journey 25 years on

The space telescope was seen as a costly flop on its first release
Did Conservative peer Lord Ashcroft quit the House of Lords to become a non-dom?

Did Lord Ashcroft quit the House of Lords to become a non-dom?

A document seen by The Independent shows that a week after he resigned from the Lords he sold 350,000 shares in an American company - netting him $11.2m
Apple's ethnic emojis are being used to make racist comments on social media

Ethnic emojis used in racist comments

They were intended to promote harmony, but have achieved the opposite
Sir Kenneth Branagh interview: 'My bones are in the theatre'

Sir Kenneth Branagh: 'My bones are in the theatre'

The actor-turned-director’s new company will stage five plays from October – including works by Shakespeare and John Osborne
The sloth is now the face (and furry body) of three big advertising campaigns

The sloth is the face of three ad campaigns

Priya Elan discovers why slow and sleepy wins the race for brands in need of a new image
How to run a restaurant: As two newbies discovered, there's more to it than good food

How to run a restaurant

As two newbies discovered, there's more to it than good food
Record Store Day: Remembering an era when buying and selling discs were labours of love

Record Store Day: The vinyl countdown

For Lois Pryce, working in a record shop was a dream job - until the bean counters ruined it
Usher, Mary J Blige and to give free concert as part of the Global Poverty Project

Mary J Blige and to give free concert

The concert in Washington is part of the Global Citizen project, which aims to encourage young people to donate to charity
10 best tote bags

Accessorise with a stylish shopper this spring: 10 best tote bags

We find carriers with room for all your essentials (and a bit more)
Paul Scholes column: I hear Manchester City are closing on Pep Guardiola for next summer – but I'd also love to see Jürgen Klopp managing in England

Paul Scholes column

I hear Manchester City are closing on Pep Guardiola for next summer – but I'd also love to see Jürgen Klopp managing in England